We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01317394
First Posted: March 17, 2011
Last Update Posted: March 17, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Taipei Medical University WanFang Hospital
March 15, 2011
March 17, 2011
March 17, 2011
December 2010
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation
Retrospective Study and Analysis of Micafungin for Non-albican Candidemia: Efficacy, Risk Factor and Clinical Manifestation
This study is a retrospective research in order to compare and analysis the risk factor, clinical manifestation and efficacy of albicans candidemia by pulling medical records. We hope that this retrospective research will let us understand the method of treatment and prevention of albicans candidemia in order to improve the quality of healthcare.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
non-albicans candidemia patients
Non-albicans Candidemia
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
February 2011
Not Provided

Inclusion Criteria:

  • above 20 years old
  • hospital patients
  • albicans candidemia patients

Exclusion Criteria:

  • pregnant patients or patients under 16 years old
  • liver cirrhosis and Child C
Sexes Eligible for Study: All
20 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
 
NCT01317394
99078
No
Not Provided
Not Provided
Wen-Sen Lee, Department of Infectious Disease, WanFang Hospital
Taipei Medical University WanFang Hospital
Not Provided
Principal Investigator: Wen-Sen Lee Taipei Medical University WanFang Hospital
Taipei Medical University WanFang Hospital
March 2011